The invention relates generally to a medical device, and more particularly to a container for containing medicament delivery devices.
Exposure to certain substances, such as, for example, peanuts, shellfish, bee venom, certain drugs, toxins, and the like, can cause allergic reactions in some individuals. Such allergic reactions can, at times, lead to anaphylactic shock, which can cause a sharp drop in blood pressure, hives, and/or severe airway constriction. Accordingly, responding rapidly to mitigate the effects from such exposures can prevent injury and/or death. For example, in certain situations, an injection of epinephrine (i.e., adrenaline) can provide substantial and/or complete relief from the allergic reaction. In other situations, for example, an injection of an antidote to a toxin can greatly reduce and/or eliminate the harm potentially caused by the exposure. Because emergency medical facilities may not be available when an individual is suffering from an allergic reaction, some individuals carry a medicament delivery device, such as, for example, an auto-injector, to rapidly self-administer a medicament in response to an allergic reaction.
For a variety of reasons, however, some individuals who are susceptible to allergic reactions may not carry such a medicament delivery device. For example, some individuals may not be aware of their susceptibility to allergic reactions. Other individuals may be are aware of their susceptibility but may, at times, forget to carry a medicament delivery device and/or leave it in a location where it is impractical to use in an emergency. In some situations, the consequences of an individual leaving home without having a medicament delivery device can be compounded when, for example, the individual is going to an environment that poses a greater likelihood of exposure to the substances that can trigger an allergic reaction. For example, an individual who is allergic to peanuts may be at a much greater risk when eating at a restaurant than when eating at home.
Moreover, some known medicament delivery devices require several steps to deliver the medicament into the patient. For example, to actuate some known auto-injectors, the user must remove a protective cap, remove a locking device, place the auto-injector in a proper position against the body and then press a button to actuate the auto-injector. Failure to complete these operations properly can result in an incomplete injection and/or injection into an undesired location of the body. In certain instances, for example, users who have become confused in the operation of some known auto-injectors have inadvertently injected the medicament into their thumb by improperly positioning the auto-injector.
The likelihood of improper use of known medicament delivery devices can be compounded by the nature of the user and/or the circumstances under which such devices are used. For example, many users are not trained medical professionals and may have never been trained in the operation of such devices. Moreover, in certain situations, the user may not be the patient, and may therefore have no experience with the medicament delivery device. Similarly, because some known medicament delivery devices are configured to be used relatively infrequently in response to an allergic reaction or the like, even those users familiar with the device and/or who have been trained may not be well practiced at operating the device. Finally, such devices are often used during an emergency situation, during which even experienced and/or trained users may be subject to confusion, panic and/or the physiological effects of the condition requiring treatment.
Some known medicament delivery devices include printed instructions to inform the user of the steps required to properly deliver the medicament. Such printed instructions, however, can be inadequate for the class of users and/or the situations described above. Moreover, because some known medicament delivery devices, such as, for example, auto-injectors, pen injectors, inhalers or the like, can be compact, such printed instructions may be too small to read and comprehend during an emergency situation.
Thus, a need exists for a container for medicament delivery devices that can be located in environments in which some individuals may have a higher than normal risk of having an allergic reaction. Additionally, such containers should provide instructions for using the medicament delivery devices contained therein that can be easily understood by an untrained user in any type of situation.
Apparatuses for containing medicament delivery devices are described herein. In one embodiment, an apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices, such as, for example, pen injectors, auto-injectors, inhalers or the like. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction of the first medicament delivery device and/or the second medicament delivery device.
In some embodiments, an apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices, such as, for example, pen injectors, auto-injectors, inhalers or the like. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction of the first medicament delivery device and/or the second medicament delivery device.
In some embodiments, an apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The first medicament delivery device includes a label configured to output a signal associated with at least one of a contents of the first medicament delivery device, an expiration date of the first medicament delivery device, a dosage of the first medicament delivery device or a use instruction associated with the first medicament delivery device. In this manner, the first electronic output can be associated with the signal received by the electronic circuit system. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction of the first medicament delivery device and/or the second medicament delivery device.
In some embodiments, a kit includes a medicament delivery device and a container. The container defines an internal region configured to contain the medicament delivery device. The container includes a movable portion, an electronic circuit system, a first switch and a second switch. The movable portion has a first position, in which the movable portion covers the internal region of the container, and a second position, in which the internal region of the container is exposed to an area outside the container. The first switch is configured to move between a first state and a second state when the movable portion moves between its first position and its second position. The first switch is operatively coupled to the electronic circuit system such that the electronic circuit system is configured to output a first electronic output when the first switch is moved from its first state to its second state. The first electronic output can be, for example, a visual output, an audible output or a haptic output. The second switch is configured to move between a first state and a second state when the medicament delivery device is removed from the internal region of the container. The second switch is operatively coupled to the electronic circuit system such that the electronic circuit system is configured to output a second electronic output when the second switch is moved from its first state to its second state. The second electronic output, which includes an instruction for using the medicament delivery device, can be, for example, a visual output (e.g. a video showing the proper use of the medicament delivery device), an audible output (e.g., a voice recording providing instructions for use) or a haptic output (e.g., a vibration indicating the location of a particular item).
In some embodiments, an apparatus includes a container, a retainer and an electronic circuit system. The container defines an internal region configured to contain at least a portion of a medicament delivery device, such as, for example a pen injector. The retainer is configured to be movably coupled to the container and to retain the portion of the medicament delivery device within the internal region defined by the container. The electronic circuit system is configured to output a first electronic output when the retainer is moved relative to the container and a second electronic output when the medicament delivery device is removed from the internal region. At least one of the first electronic output or the second electronic output is associated with an instruction for using the medicament delivery device.
In some embodiments, an apparatus includes a container, a retainer, an electronic circuit system and a label. The container defines an internal region configured to contain at least a portion of a medicament delivery device, such as, for example a pen injector. The retainer is configured to be movably coupled to the container and to retain the portion of the medicament delivery device within the internal region defined by the container. The label is configured to be coupled to the medicament delivery device and contain information associated with the medicament delivery device in a machine-readable format. The electronic circuit system is configured to output a first electronic output when the retainer is moved relative to the container and a second electronic output when the medicament delivery device is removed from the internal region. The electronic circuit system is further configured to receive the information contained on the label include at least a portion of the information in the first electronic output and/or the second electronic output. At least one of the first electronic output or the second electronic output is associated with an instruction for using the medicament delivery device.
As shown in
Similarly, as shown in
Although the second electronic output OP2 is described as being different than the first electronic output OP1, in some embodiments, the second electronic output OP2 can be the same as the first electronic output OP1. In some embodiments, for example, the second electronic output OP2 can include the same information as previously output via the first electronic output OP1 along with additional information. In this manner, the second electronic output OP2 can confirm the instructions and/or information provided by the first electronic output OP1.
The container 110 can be any container suitable for containing a plurality of medicament delivery devices. For example, in some embodiments, the container 110 can be a box-like structure that includes a lid or cover that can be repeatedly opened and closed to selectively expose the internal region 112 of the container 110 to an area outside the container 110. In other embodiments, the container 110 can include a frangible portion that can be irreversibly moved to expose the internal region 112 of the container 110 to allow access to the first medicament delivery device 150 and/or the second medicament delivery device 152.
The container 110 can be either portable or permanently installed at a particular location. For example, in some embodiments, the container 110 can be configured to be moved by the user. For example, in such embodiments, a user may carry the container 110 to events, such as picnics, field trips, children's camps or the like, where the likelihood of use increases. In other embodiments, the container 110 can be removably coupled to a mounting area within a building, such as a restaurant, airport and/or shopping mall. In this manner, when a user recognizes an emergency situation, the user can locate the container 110 and move it to the area in which the emergency situation is occurring. In yet other embodiments, the container 110 can be permanently coupled to a wall of a building.
The container 110 can be constructed from any suitable material, such as, for example, plastic, metal alloys, insulative foam, fabric or any combination thereof. In some embodiments, for example, the container 110 can include a hard, plastic outer casing and an insulative, shock-absorbing inner liner. In some embodiments, the container 110 can be constructed from a waterproof material and/or can be configured to float. In some embodiments, the container 110 can be constructed from a material configured to prevent light from reaching the interior region 112 of the container. In this manner, the container can prevent the medicaments contained therein from being exposed to light that can impact the chemical structure and/or stability of the medicament.
Although the container 110 is shown and described above as containing a first medicament delivery device 150 and a second medicament delivery device 152 having similar sizes and/or shapes, in some embodiments, a container can be configured to include medicament delivery devices of different sizes and/or shapes. For example, in some embodiments, a container can be configured to include a medical injector having a long, narrow shape and an inhaler having a wider shape.
The electronic circuit system 230 includes a first switch 236 associated with the first retainer 214 and a second switch 237 associated with the second retainer 216. The first switch 236 is configured move between a first state (e.g., closed) and a second state (e.g., opened) when the first medicament delivery device 250 is removed from the first retainer 214. Similarly, the second switch 237 is configured move between a first state and a second state when the second medicament delivery device 252 is removed from the second retainer 216. In this manner, the electronic circuit system 230 can output electronic outputs based on the state of the first switch 236 and/or the second switch 237.
More particularly, as shown in
The first retainer 214 can be any structure that cooperates with the first medicament delivery device 250 to retain the first medicament delivery device 250 within the internal region 212 of the container 210. Similarly, the second retainer 216 can be any structure that cooperates with the second medicament delivery device 252 to retain the second medicament delivery device 252 within the internal region 212 of the container 210. In some embodiments, for example, the first retainer 214 can be a recessed portion (not shown in
In some embodiments, the first retainer 214 can be uniquely associated with the first medicament delivery device 250 and/or the second retainer 214 can be uniquely associated with the second medicament delivery device 252. In this manner, the first medicament delivery device 250 can only be associated with the first switch 236 and the second medicament delivery device 252 can only be associated with the second switch 237. Said another way, such an arrangement prevents second medicament delivery 252 from inadvertently being retained by the first retainer 214, which could result in the electronic circuit system 230 outputting the first electronic output OP3 when the second medicament delivery device 252 is removed from the container 210 or vice-versa. Moreover, by using the first retainer 214 and the second retainer 216, the internal region 212 can be adapted to contain a variety of different medicament delivery devices having different sizes, shapes and/or characteristics. For example, in those embodiments in which the first retainer 214 is a recessed portion of the internal region 212, the shape of the recess can be uniquely associated with a shape of the first medicament delivery device 250, thereby preventing the second medicament delivery device 252 from being received within the first retainer 214. Similarly, in some embodiments, the second retainer 216 can be a recessed portion of the internal region 212, of the type described above, having a shape to receive at least a portion of the second medicament delivery device 252.
Although the retainers are described above as cooperating with the medicament delivery devices to retain the medicament delivery devices within the internal region 212 of the container 210, in some embodiments, the first retainer 214 and/or the second retainer 216 can perform additional functions. For example, in some embodiments, the first retainer 214 can electronically couple an electronic circuit system (not shown in
The electronic circuit system 330 is configured to output a first electronic output (not shown in
Moreover, as shown in
In some embodiments, for example, the first electronic output can be associated with an audible message including information contained from the signal S, such as for example, the expiration date of the medicament contained within the first medicament delivery device 350. Such an audible message can state, for example, “You have removed an auto-injector containing DOSE mg of Epinephrine. The expiration date of this device is EXPIRATION DATE. If the current date is later than EXPIRATION DATE please select another auto-injector from within the container.” In other embodiments, for example, the first electronic output can be a message providing the user with use instructions or other information contained within the signal S that is uniquely associated with the first medicament delivery device 350. For example, such a message can prompt a user to call a phone number unique to the manufacturer of the first medicament delivery device 350 for assistance before, during or after the use of the first medicament delivery device 350. In yet other embodiments, as described in more detail herein, the electronic circuit system 330 can automatically call such a phone number when the first medicament delivery device 350 is removed from the internal region 312 of the container 310.
The label 354 can be any device suitable for outputting the signal S that includes information associated with the first medicament delivery device 350 and that can be received by the electronic circuit system 330. For example, in some embodiments, the label 354 can include a passive RFID tag. In other embodiments, the label can include an active RFID tag.
In some embodiments, label 354 can include its own electronic circuit system, similar to the electronic circuit systems described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety. In such embodiments, the label 354 can produce multiple signals associated with the first medicament delivery device 350 based on the ongoing status of the medicament delivery device 350 as determined by the electronic circuit system included within the label 354. For example, in some embodiments, the first medicament delivery device 350 can include its own electronic circuit system having various switches, sensors or the like, such that when the user completes certain operations (e.g., removing the needle guard, removing the safety tab, etc.), a signal S can be transmitted to the electronic circuit system 330 of the container 310. The electronic circuit system 330 of the container 310 can then output one or more electronic outputs of the type described above to provide information to the user that is unique to the status of the first medicament delivery device 350.
Although the label 354 is shown and described as outputting a signal S that can be received by the electronic circuit system 330, in other embodiments, the label 354 can be a passive device that does not output an electronic signal, but rather, contains information associated with the medicament delivery device 350 in a machine-readable format. For example, in such embodiments, the label 354 can include a bar code portion containing information associated with the medicament delivery device 350. In other embodiments, the label 354 can include a magnetic strip containing information associated with the medicament delivery device 350.
The electronic circuit systems shown and described above can include many components operatively coupled to perform the functions described herein For example,
The visual output device 442 can be any suitable device for producing visual indicia, such as, light-emitting diodes (LEDs), liquid-crystal display (LCD) screens, optical polymers, fiber optic components or the like. Similarly, the audio output device 444 can be any suitable device for producing sound, such as a micro-speaker a piezo-electric transducer or the like. Such sound output can include, for example, an alarm, a series of beeps, recorded speech or the like.
In some embodiments, the electronic circuit system 430 includes a network interface 440 configured to operatively couple the electronic circuit system 430 to a remote device 441, either via a wired connection or via a wireless connection. The remote device 441 can be, for example, a remote communications network, a computer, a cell phone, a personal digital assistant (PDA) or the like. Such an arrangement can be used, for example, to download replacement processor-readable code 435 from a central network to the memory device 434. In some embodiments, the electronic circuit system 430 can download information associated with a medicament delivery device, such as an expiration date, a recall notice, updated use instructions or the like.
The network interface 440 can also be configured to transmit information from the electronic circuit system 430 to a central network, such as, for example, an emergency response network. In some embodiments, for example, the electronic circuit system 430 can notify an emergency responder when a medicament delivery device is removed and/or actuated. In other embodiments, the electronic circuit system 430 can transmit information to a third party, such as a physician, an emergency contact and/or the manufacturer of a medicament device, when the medicament delivery device is removed and/or actuated. Such information can include, for example, the location of use, the date and/or time of use or the like.
As shown in
The processor 432 can be a commercially-available processing device dedicated to performing one or more specific tasks. For example, in some embodiments, the microprocessor 432 can be a commercially-available microprocessor, such as the Sonix SNC 12060 voice synthesizer. Alternatively, the processor 432 can be an application-specific integrated circuit (ASIC) or a combination of ASICs, which are designed to perform one or more specific functions. In yet other embodiments, the processor 132 can be an analog or digital circuit, or a combination of multiple circuits.
The memory device 434 can include one or more types of memory. For example, in some embodiments, the memory device 434 can include a read only memory (ROM) component and a random access memory (RAM) component. The memory device 432 can also include other types of memory suitable for storing data in a form retrievable by the processor 432, for example, electronically-programmable read only memory (EPROM), erasable electronically-programmable read only memory (EEPROM) and/or flash memory.
Although the medical devices shown and described above include one electronic circuit system, in some embodiments, a medical device can include multiple electronic circuit systems configured to perform the functions described herein.
Although the containers shown and described above include multiple medicament delivery devices, in some embodiments, a container can include only one medicament delivery device. For example,
The container 510 also includes a movable portion 518, such as, for example, a hinged lid, that has a first position (see
The electronic circuit system 530 is operatively coupled to a first switch 536 and a second switch 537. The first switch 536 is configured to move between a first state (e.g., closed) and a second state (e.g., opened) when the movable portion 518 moves between its first position and its second position, as indicated by arrow E in
The second switch 537 is configured to move between a first state (e.g., closed) and a second state (e.g., opened) when the medicament delivery device 550 is removed from the internal region 512 of the container 510, as indicated by the arrow F in
Although the movable member 518 is shown and described as being a hinged lid, in some embodiments, the movable member can be coupled to the container in any suitable fashion. For example, in some embodiments, the movable member 518 can be a removable cover that is slidingly coupled to the container. In other embodiments, the movable member 518 can be a removable cover that is threadedly coupled to the container (i.e., a removable cap). In yet other embodiments, the movable member 518 can be a removable cover that is coupled to the container via an interference fit. In yet other embodiments, the movable member 518 can be a frangible cover that is irreversibly removed from the container during use of the medical device. For example, in some embodiments the movable member 518 can be a frangible cover that provides a tamperproof seal, a sanitary seal, or the like.
Although the containers are shown and described above as being rigid, box-like containers, in other embodiments, a container can have any suitable shape and/or flexibility. For example, in some embodiments, a container can be a flexible, pouch-like container. Such a container can be more easily carried in certain circumstances, such as, for example at outdoor events (e.g., children's camps, concerts, picnics or the like). In other embodiments, a container can be a tube configured to contain all or a portion of a medicament delivery device. For example,
The retainer 618, which can be, for example, a mating tube-shaped lid, is movably coupled to the container 610 to retain the medicament delivery device 650 within the internal region 612. Said another way, the retainer 618 has a first position (
The medical device 600 includes an electronic circuit system 630 coupled to the container 610. The electronic circuit system 630 includes a speaker 644 and a light emitting diode (LED) 642 for providing an electronic output associated with the use of the medicament delivery device 650, as described herein. In some embodiments, the electronic circuit system can be, for example, a flexible circuit included in a label coupled to an outer surface of the container 610, similar to the electronic circuit systems described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety.
The electronic circuit system 630 is configured to output a first electronic output via the LED 642 and/or the speaker 644 when the retainer 618 is moved relative to the container 610, as indicated by arrows G and/or G′ in
The electronic circuit system 630 can be prompted to output the first electronic output by a switch 636 configured to change states when the retainer 618 is moved relative to the container 610. The switch 636 can be any suitable electronic switch having at least two states. For example, in some embodiments, the switch 636 can be a single-use “tear-through” switch, as described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety. For example, the switch 636 can be irreversibly moved from a first state to a second state when the retainer 618 is moved relative to the container 610. In other embodiments, a switch can be a multi-use switch, such as a microswitch.
Similarly, the electronic circuit system 630 is configured to output a second electronic output via the LED 642 and/or the speaker 644 when the medicament delivery device 650 is removed from the internal region 612 defined by the container 610, as shown by arrow H in
As shown in
The label 654 can be any device suitable for containing information associated with the medicament delivery device 650 in a machine-readable format. For example, in some embodiments, the label 654 can include a bar code portion containing information associated with the medicament delivery device 650. In other embodiments, the label 654 can include a magnetic strip containing information associated with the medicament delivery device 650. In yet other embodiments, the label 654 can include a passive RFID tag containing information associated with the medicament delivery device 650. In yet other embodiments, the label 654 can include an active RFID tag containing information associated with the medicament delivery device 650.
Although the retainer 618 is shown as covering the internal region 612 defined by the container 610, in some embodiments, the retainer 618 can allow access to the internal region 612 while still retaining the medicament delivery device 650 within the internal region 612. For example, in some embodiments, the retainer 618 can be a clip, a strap or the like.
Although the medicament delivery device 650 is shown in
While various embodiments of the invention have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above.
For example, although electronic circuit systems are shown and described above as outputting one or more outputs directed towards a single, immediate user, in some embodiments, an electronic circuit system can output multiple outputs directed towards multiple different classes of users. For example, in some embodiments, an electronic circuit system can output a first electronic output to the immediate user and second electronic output to a remotely located emergency response team. In such embodiments, the second electronic output can be, for example, a phone call, a page, an e-mail or the like. For example, in some embodiments, the second electronic output can be an e-mail to the parents and/or caregivers of a child. Moreover, such a second electronic output can be transmitted either wirelessly or through a wired network.
Although the electronic circuit systems are shown and described above as outputting one or more outputs in response to one or more switches, in other embodiments an electronic circuit system can output an electronic output in response to any number of different inputs. For example, in some embodiments, an electronic circuit system can output an electronic output based on input from the user provided via a keyboard, a touch screen, a microphone or any other suitable input device. In this manner, the electronic outputs can be produced in response to direct feedback from the user.
In other embodiments, an electronic circuit system can output an electronic output based on a sensor included in the container and/or the medicament delivery device. Such a sensor can include, for example, a proximity sensor (e.g., to determine the position of the medicament delivery device), a temperature sensor, a pressure sensor, an optical sensor or the like. For example, in some embodiments, the container can include a temperature sensor configured to sense the temperature of the medicament contained within the medicament delivery device. In this manner, the electronic circuit system can output an instruction and/or a status message when the medicament is too cold for effective delivery. For example, in some embodiments, when the medicament is too cold for effective delivery (this may occur, for example, if the container is being used in an outdoor setting), the electronic circuit system can output a message, such as, for example, “Medicament is too cold—please briskly rub the auto-injector between your hands before using.”
Although the electronic circuit systems are shown and described above as outputting a single electronic output in response to an input (e.g., the removal of a medicament delivery device, the change in position of a hinged lid, etc.), in some embodiments, an electronic circuit system can output a sequence of electronic outputs in response to such an input. In some embodiments, for example, when a medicament delivery device is removed from a container, an electronic circuit system can output a predetermined sequence of use instructions over a predetermined time period. For example, upon removing the medicament delivery device, the first instruction can be an audible output indicating the type of medicament delivery device removed. After a predetermined time period, the electronic circuit system can then output a second instruction, which can be a visual output instructing the user in how to diagnose the patient and/or prepare the patient for the medicament. In a similar manner, the electronic circuit system can provide additional outputs to instruct the user in the use of the medicament delivery device. Moreover, in some embodiments, the electronic circuit system can output an electronic output instructing the user in post-use procedures, such as for example, the disposal of the medicament delivery device, instructions for follow-up treatment or the like.
For example, although the electronic circuit systems are shown and described above as being configured to output primarily audible and visual outputs, in other embodiments, an electronic circuit system can be configured to produce any suitable output. For example, in some embodiments, an electronic circuit system can produce a haptic output, such as a vibratory output produced by a piezo-electric actuator. In other embodiments, an electronic circuit system can produce a thermal output, produced by a heating or cooling element.
Although the electronic circuit systems are shown and described above as outputting recorded speech in English, in other embodiments, the electronic circuit system can output recorded speech in any language. In yet other embodiments, the electronic circuit system can output recorded speech in multiple languages. In yet other embodiments, the user can select the language in which the recorded speech is to be output.
Although the medicament delivery devices have been shown and described above as being primarily single-use medical injectors, in some embodiments a medicament delivery device can include any suitable device for delivering one or more doses of a medicament into a patient's body. For example, in some embodiments, a medicament delivery device can be a pen injector containing multiple doses of a chronic-care medicament, such as, for example, insulin. In such embodiments, an electronic circuit system can output instructions associated with not only an initial use of the medicament delivery device, but also associated with repeated uses, dosage monitoring or the like. In other embodiments, a medicament delivery device can include a transdermal medicament delivery device, an inhaler or a nasal medicament delivery device.
Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments where appropriate. For example, in some embodiments a medical device can include a container including an electronic circuit system, two or more medicament delivery devices and a movable portion. In such embodiments, each of the medicament delivery devices can be associated with a switch. Moreover, the movable portion can also be associated with a switch. In this manner, the electronic circuit system can be configured to output a first electronic output when the movable portion is moved, a second electronic output when the first medicament delivery device is removed from the container and a third electronic output when the second medicament delivery device is removed from the container.
This application is a continuation of U.S. patent application Ser. No. 11/671,025, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Feb. 5, 2007, which is a continuation-in-part of U.S. patent application Ser. No. 11/621,236, now U.S. Pat. No. 7,731,686, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which claims priority to U.S. Provisional Application Ser. No. 60/787,046, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Mar. 29, 2006, which is incorporated herein by reference in its entirety. U.S. patent application Ser. No. 11/621,236 is a continuation-in-part of U.S. patent application Ser. No. 10/572,148, now U.S. Pat. No. 7,749,194, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Mar. 16, 2006, which is a national stage filing under 35 U.S.C. §371 of International Patent Application No. PCT/US2006/003415, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Feb. 1, 2006, which claims priority to U.S. Provisional Application Ser. No. 60/648,822, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Feb. 1, 2005 and U.S. Provisional Application Ser. No. 60/731,886, entitled “Auto-Injector with Feedback,” filed Oct. 31, 2005, each of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2960087 | Uytenbogaart | Nov 1960 | A |
3055362 | Uytenbogaart | Sep 1962 | A |
3115133 | Morando | Dec 1963 | A |
3426448 | Sarnoff | Feb 1969 | A |
3688765 | Gasaway | Sep 1972 | A |
3768472 | Hodosh et al. | Oct 1973 | A |
3795061 | Sarnoff et al. | Mar 1974 | A |
3945379 | Pritz et al. | Mar 1976 | A |
4108177 | Pistor | Aug 1978 | A |
4149394 | Sornes | Apr 1979 | A |
4360019 | Portner et al. | Nov 1982 | A |
4424057 | House | Jan 1984 | A |
4441629 | Mackal | Apr 1984 | A |
4484910 | Sarnoff | Nov 1984 | A |
4573976 | Sampson et al. | Mar 1986 | A |
4596556 | Morrow et al. | Jun 1986 | A |
4610666 | Pizzino | Sep 1986 | A |
4613328 | Boyd | Sep 1986 | A |
4617557 | Gordon | Oct 1986 | A |
4624660 | Mijers et al. | Nov 1986 | A |
4640686 | Dalling et al. | Feb 1987 | A |
4643721 | Brunet | Feb 1987 | A |
4666430 | Brown et al. | May 1987 | A |
4673657 | Christian | Jun 1987 | A |
4689042 | Sarnoff et al. | Aug 1987 | A |
4693708 | Wanderer et al. | Sep 1987 | A |
4781697 | Slaughter | Nov 1988 | A |
4782841 | Lopez | Nov 1988 | A |
4784652 | Wikström | Nov 1988 | A |
4795433 | Sarnoff | Jan 1989 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4865582 | Sibalis | Sep 1989 | A |
4874382 | Lindemann et al. | Oct 1989 | A |
4894054 | Miskinyar | Jan 1990 | A |
4906235 | Roberts | Mar 1990 | A |
4915695 | Koobs | Apr 1990 | A |
4941880 | Burns | Jul 1990 | A |
4959056 | Dombrowski et al. | Sep 1990 | A |
4968302 | Schluter et al. | Nov 1990 | A |
4983164 | Hook et al. | Jan 1991 | A |
5000736 | Kaufhold, Jr. et al. | Mar 1991 | A |
5024656 | Gasaway et al. | Jun 1991 | A |
5037306 | van Schoonhoven | Aug 1991 | A |
5038023 | Saliga | Aug 1991 | A |
5041088 | Ritson et al. | Aug 1991 | A |
5062603 | Smith et al. | Nov 1991 | A |
5064413 | McKinnon et al. | Nov 1991 | A |
5071353 | van der Wal | Dec 1991 | A |
5085642 | Sarnoff et al. | Feb 1992 | A |
5092843 | Monroe et al. | Mar 1992 | A |
5125898 | Kaufhold, Jr. et al. | Jun 1992 | A |
5167641 | Schmitz | Dec 1992 | A |
5199949 | Haber et al. | Apr 1993 | A |
5224936 | Gallagher | Jul 1993 | A |
5240146 | Smedley et al. | Aug 1993 | A |
5281198 | Haber et al. | Jan 1994 | A |
5286258 | Haber et al. | Feb 1994 | A |
5298023 | Haber et al. | Mar 1994 | A |
5312326 | Myers et al. | May 1994 | A |
5314412 | Rex | May 1994 | A |
5314502 | McNichols et al. | May 1994 | A |
5343519 | Feldman | Aug 1994 | A |
5344407 | Ryan | Sep 1994 | A |
5354284 | Haber et al. | Oct 1994 | A |
5356376 | Milijasevic et al. | Oct 1994 | A |
5363842 | Mishelevich et al. | Nov 1994 | A |
5380281 | Tomellini et al. | Jan 1995 | A |
5383851 | McKinnon, Jr. et al. | Jan 1995 | A |
5394866 | Ritson et al. | Mar 1995 | A |
5399163 | Peterson et al. | Mar 1995 | A |
5405362 | Kramer et al. | Apr 1995 | A |
5417660 | Martin | May 1995 | A |
5466217 | Myers et al. | Nov 1995 | A |
5514135 | Earle | May 1996 | A |
5558679 | Tuttle | Sep 1996 | A |
5567160 | Massino | Oct 1996 | A |
5568555 | Shamir | Oct 1996 | A |
5569192 | van der Wal | Oct 1996 | A |
5584815 | Pawelka et al. | Dec 1996 | A |
5615771 | Hollister | Apr 1997 | A |
5616132 | Newman | Apr 1997 | A |
5645534 | Chanoch | Jul 1997 | A |
5662612 | Niehoff | Sep 1997 | A |
5681291 | Galli | Oct 1997 | A |
5692492 | Bruna et al. | Dec 1997 | A |
5695476 | Harris | Dec 1997 | A |
5697916 | Schraga | Dec 1997 | A |
5716338 | Hjertman et al. | Feb 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5792190 | Olson et al. | Aug 1998 | A |
5800397 | Wilson et al. | Sep 1998 | A |
5805423 | Wever et al. | Sep 1998 | A |
5809997 | Wolf | Sep 1998 | A |
5813397 | Goodman et al. | Sep 1998 | A |
5814020 | Gross | Sep 1998 | A |
5823363 | Cassel | Oct 1998 | A |
5832488 | Eberhardt | Nov 1998 | A |
5837546 | Allen et al. | Nov 1998 | A |
RE35986 | Ritson et al. | Dec 1998 | E |
5846089 | Weiss et al. | Dec 1998 | A |
5848988 | Davis | Dec 1998 | A |
5852590 | de la Huerga | Dec 1998 | A |
5853292 | Eggert et al. | Dec 1998 | A |
5868713 | Klippenstein | Feb 1999 | A |
5868721 | Marinacci et al. | Feb 1999 | A |
D407487 | Greubel et al. | Mar 1999 | S |
5925021 | Castellano et al. | Jul 1999 | A |
5928195 | Malamud | Jul 1999 | A |
5941857 | Nguyen et al. | Aug 1999 | A |
5964739 | Champ | Oct 1999 | A |
5970457 | Brant et al. | Oct 1999 | A |
5971953 | Bachynsky | Oct 1999 | A |
5991655 | Gross et al. | Nov 1999 | A |
6015438 | Shaw | Jan 2000 | A |
6039713 | Botich et al. | Mar 2000 | A |
6045534 | Jacobsen et al. | Apr 2000 | A |
6062901 | Liu et al. | May 2000 | A |
6063053 | Castellano et al. | May 2000 | A |
6074213 | Hon | Jun 2000 | A |
6077106 | Mish | Jun 2000 | A |
6084526 | Blotky et al. | Jul 2000 | A |
6086562 | Jacobsen et al. | Jul 2000 | A |
6096002 | Landau | Aug 2000 | A |
6099504 | Gross et al. | Aug 2000 | A |
6102896 | Roser | Aug 2000 | A |
6119684 | Nöhl et al. | Sep 2000 | A |
6149626 | Rachynsky et al. | Nov 2000 | A |
6158613 | Novosel et al. | Dec 2000 | A |
6161281 | Dando et al. | Dec 2000 | A |
6165155 | Jacobsen et al. | Dec 2000 | A |
6175752 | Say | Jan 2001 | B1 |
6179812 | Botich et al. | Jan 2001 | B1 |
6192891 | Gravel et al. | Feb 2001 | B1 |
6193695 | Rippstein, Jr. | Feb 2001 | B1 |
6202642 | McKinnon et al. | Mar 2001 | B1 |
6210359 | Patel et al. | Apr 2001 | B1 |
6210369 | Wilmot et al. | Apr 2001 | B1 |
6219587 | Ahlin et al. | Apr 2001 | B1 |
6221045 | Duchon et al. | Apr 2001 | B1 |
6221055 | Shaw et al. | Apr 2001 | B1 |
6245046 | Sibbitt | Jun 2001 | B1 |
6258063 | Haar et al. | Jul 2001 | B1 |
6259654 | de la Huerga | Jul 2001 | B1 |
6264629 | Landau | Jul 2001 | B1 |
6270455 | Brown | Aug 2001 | B1 |
6284765 | Caffrey | Sep 2001 | B1 |
6312412 | Saied et al. | Nov 2001 | B1 |
6317630 | Gross et al. | Nov 2001 | B1 |
6321654 | Robinson | Nov 2001 | B1 |
6334070 | Nova et al. | Dec 2001 | B1 |
6364866 | Furr et al. | Apr 2002 | B1 |
6371939 | Bergens et al. | Apr 2002 | B2 |
6377848 | Garde et al. | Apr 2002 | B1 |
6387078 | Gillespie, III | May 2002 | B1 |
6398760 | Danby | Jun 2002 | B1 |
6405912 | Giannou | Jun 2002 | B2 |
6411567 | Niemiec et al. | Jun 2002 | B1 |
6413236 | Van Dyke | Jul 2002 | B1 |
6425897 | Overes et al. | Jul 2002 | B2 |
6428517 | Hochman et al. | Aug 2002 | B1 |
6428528 | Sadowski | Aug 2002 | B2 |
6475181 | Potter et al. | Nov 2002 | B1 |
6478769 | Parker | Nov 2002 | B1 |
6478771 | Lavi et al. | Nov 2002 | B1 |
6494863 | Shaw et al. | Dec 2002 | B1 |
6500150 | Gross et al. | Dec 2002 | B1 |
6514230 | Munk et al. | Feb 2003 | B1 |
6529446 | de la Huerga | Mar 2003 | B1 |
6530900 | Sahar et al. | Mar 2003 | B1 |
6530904 | Edwards et al. | Mar 2003 | B1 |
6535714 | Melker et al. | Mar 2003 | B2 |
6540672 | Simonsen et al. | Apr 2003 | B1 |
6540675 | Aceti et al. | Apr 2003 | B2 |
6544234 | Gabriel | Apr 2003 | B1 |
6551276 | Mann et al. | Apr 2003 | B1 |
6551298 | Zhang et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey, III et al. | May 2003 | B1 |
6560471 | Heller et al. | May 2003 | B1 |
6565533 | Smith et al. | May 2003 | B1 |
6569123 | Alchas | May 2003 | B2 |
6572584 | Shaw et al. | Jun 2003 | B1 |
6574166 | Niemiec | Jun 2003 | B2 |
6575939 | Brunel | Jun 2003 | B1 |
RE38189 | Walker et al. | Jul 2003 | E |
6585685 | Staylor et al. | Jul 2003 | B2 |
6585698 | Packman et al. | Jul 2003 | B1 |
6589158 | Winkler | Jul 2003 | B2 |
6595956 | Gross et al. | Jul 2003 | B1 |
6633796 | Pool et al. | Oct 2003 | B1 |
6641566 | Douglas et al. | Nov 2003 | B2 |
6645181 | Lavi et al. | Nov 2003 | B1 |
6659980 | Moberg et al. | Dec 2003 | B2 |
6679862 | Diaz et al. | Jan 2004 | B2 |
6689093 | Landau | Feb 2004 | B2 |
6702778 | Hill et al. | Mar 2004 | B2 |
6707763 | Osberg et al. | Mar 2004 | B2 |
6708050 | Carim | Mar 2004 | B2 |
6722916 | Buccinna et al. | Apr 2004 | B2 |
6723077 | Pickup et al. | Apr 2004 | B2 |
6726661 | Munk et al. | Apr 2004 | B2 |
6736796 | Shekalim | May 2004 | B2 |
6743635 | Neel et al. | Jun 2004 | B2 |
6749437 | Chan | Jun 2004 | B2 |
6752781 | Landau et al. | Jun 2004 | B2 |
6767336 | Kaplan | Jul 2004 | B1 |
6770052 | Hill et al. | Aug 2004 | B2 |
6783509 | Landau et al. | Aug 2004 | B1 |
6786875 | Barker et al. | Sep 2004 | B2 |
6786885 | Hochman et al. | Sep 2004 | B2 |
6793646 | Giambattista et al. | Sep 2004 | B1 |
6803856 | Murphy et al. | Oct 2004 | B1 |
6808514 | Schneider et al. | Oct 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6817986 | Slate et al. | Nov 2004 | B2 |
6830560 | Gross et al. | Dec 2004 | B1 |
6839304 | Niemiec et al. | Jan 2005 | B2 |
6872200 | Mann et al. | Mar 2005 | B2 |
6875195 | Choi | Apr 2005 | B2 |
6883222 | Landau | Apr 2005 | B2 |
6923764 | Aceti et al. | Aug 2005 | B2 |
6936029 | Mann et al. | Aug 2005 | B2 |
6937150 | Medema et al. | Aug 2005 | B2 |
6942646 | Langley et al. | Sep 2005 | B2 |
6946299 | Neel et al. | Sep 2005 | B2 |
6949082 | Langley et al. | Sep 2005 | B2 |
6952604 | DeNuzzio et al. | Oct 2005 | B2 |
6953445 | Wilmot et al. | Oct 2005 | B2 |
6953693 | Neel et al. | Oct 2005 | B2 |
6958691 | Anderson et al. | Oct 2005 | B1 |
6959247 | Neel et al. | Oct 2005 | B2 |
6961285 | Niemiec et al. | Nov 2005 | B2 |
6969259 | Pastrick et al. | Nov 2005 | B2 |
6979316 | Rubin et al. | Dec 2005 | B1 |
6979326 | Mann et al. | Dec 2005 | B2 |
6985870 | Martucci et al. | Jan 2006 | B2 |
6997911 | Klitmose | Feb 2006 | B2 |
7014470 | Vann | Mar 2006 | B2 |
7093595 | Nesbitt | Aug 2006 | B2 |
7113101 | Petersen et al. | Sep 2006 | B2 |
7116233 | Zhurin | Oct 2006 | B2 |
7126879 | Snyder | Oct 2006 | B2 |
7158011 | Brue | Jan 2007 | B2 |
7191916 | Clifford et al. | Mar 2007 | B2 |
7229458 | Boecker et al. | Jun 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
7299981 | Hickle et al. | Nov 2007 | B2 |
7343914 | Abrams et al. | Mar 2008 | B2 |
7351223 | Call | Apr 2008 | B2 |
7416540 | Edwards et al. | Aug 2008 | B2 |
7544188 | Edwards et al. | Jun 2009 | B2 |
7648482 | Edwards et al. | Jan 2010 | B2 |
7648483 | Edwards et al. | Jan 2010 | B2 |
7670328 | Miller et al. | Mar 2010 | B2 |
7731686 | Edwards et al. | Jun 2010 | B2 |
7731690 | Edwards et al. | Jun 2010 | B2 |
7749194 | Edwards et al. | Jul 2010 | B2 |
7947017 | Edwards et al. | May 2011 | B2 |
8021344 | Edwards et al. | Sep 2011 | B2 |
8123719 | Edwards et al. | Feb 2012 | B2 |
8172082 | Edwards et al. | May 2012 | B2 |
8231573 | Edwards et al. | Jul 2012 | B2 |
20010005781 | Bergens et al. | Jun 2001 | A1 |
20020072784 | Sheppard, Jr. et al. | Jun 2002 | A1 |
20020074345 | Schneider et al. | Jun 2002 | A1 |
20020076679 | Aman | Jun 2002 | A1 |
20020090601 | Strupat et al. | Jul 2002 | A1 |
20020096543 | Juselius | Jul 2002 | A1 |
20020183721 | Santini, Jr. et al. | Dec 2002 | A1 |
20030028145 | Duchon et al. | Feb 2003 | A1 |
20030040717 | Saulenas et al. | Feb 2003 | A1 |
20030106824 | Wilmot et al. | Jun 2003 | A1 |
20030132128 | Mazur | Jul 2003 | A1 |
20030233070 | De La Serna et al. | Dec 2003 | A1 |
20040015125 | Alexandre et al. | Jan 2004 | A1 |
20040019326 | Gilbert et al. | Jan 2004 | A1 |
20040039336 | Amark et al. | Feb 2004 | A1 |
20040039337 | Letzing | Feb 2004 | A1 |
20040039368 | Reilly et al. | Feb 2004 | A1 |
20040069667 | Tomellini et al. | Apr 2004 | A1 |
20040116854 | Abulhaj et al. | Jun 2004 | A1 |
20040138611 | Griffiths et al. | Jul 2004 | A1 |
20040143298 | Nova et al. | Jul 2004 | A1 |
20040159364 | Landau et al. | Aug 2004 | A1 |
20040220524 | Sadowski et al. | Nov 2004 | A1 |
20040249358 | McWethy et al. | Dec 2004 | A1 |
20040267204 | Brustowicz | Dec 2004 | A1 |
20050033234 | Sadowski et al. | Feb 2005 | A1 |
20050033386 | Osborn et al. | Feb 2005 | A1 |
20050055014 | Coppeta et al. | Mar 2005 | A1 |
20050062603 | Fuerst et al. | Mar 2005 | A1 |
20050088289 | Rochkind | Apr 2005 | A1 |
20050090781 | Baba et al. | Apr 2005 | A1 |
20050134433 | Sweeney, II | Jun 2005 | A1 |
20050137530 | Campbell et al. | Jun 2005 | A1 |
20050148931 | Juhasz | Jul 2005 | A1 |
20050148945 | Chen | Jul 2005 | A1 |
20050159705 | Crawford et al. | Jul 2005 | A1 |
20050165360 | Stamp | Jul 2005 | A1 |
20050168337 | Mahoney | Aug 2005 | A1 |
20050171477 | Rubin et al. | Aug 2005 | A1 |
20050182358 | Veit et al. | Aug 2005 | A1 |
20050186221 | Reynolds et al. | Aug 2005 | A1 |
20050197654 | Edman et al. | Sep 2005 | A1 |
20050261742 | Nova et al. | Nov 2005 | A1 |
20050267403 | Landau et al. | Dec 2005 | A1 |
20050277891 | Sibbitt | Dec 2005 | A1 |
20060030819 | Young et al. | Feb 2006 | A1 |
20060053036 | Coffman et al. | Mar 2006 | A1 |
20060058848 | Piraino et al. | Mar 2006 | A1 |
20060111666 | Hommann et al. | May 2006 | A1 |
20060111671 | Klippenstein | May 2006 | A1 |
20060116639 | Russell | Jun 2006 | A1 |
20060129090 | Moberg et al. | Jun 2006 | A1 |
20060169611 | Prindle | Aug 2006 | A1 |
20060189938 | Hommann et al. | Aug 2006 | A1 |
20060200077 | Righi et al. | Sep 2006 | A1 |
20060247579 | Friedman | Nov 2006 | A1 |
20060265186 | Holland et al. | Nov 2006 | A1 |
20070008113 | Spoonhower et al. | Jan 2007 | A1 |
20070074722 | Giroux et al. | Apr 2007 | A1 |
20070184847 | Hansen et al. | Aug 2007 | A1 |
20070203247 | Phillips et al. | Aug 2007 | A1 |
20070210147 | Morrone et al. | Sep 2007 | A1 |
20070213598 | Howard et al. | Sep 2007 | A1 |
20070233001 | Burroughs et al. | Oct 2007 | A1 |
20070239116 | Follman et al. | Oct 2007 | A1 |
20070260210 | Conroy | Nov 2007 | A1 |
20080059133 | Edwards et al. | Mar 2008 | A1 |
20080111685 | Olson et al. | May 2008 | A1 |
20080160492 | Campbell et al. | Jul 2008 | A1 |
20080230057 | Sutherland | Sep 2008 | A1 |
20090024112 | Edwards et al. | Jan 2009 | A1 |
20090176834 | Kottayil et al. | Jul 2009 | A1 |
20090240200 | Heneveld et al. | Sep 2009 | A1 |
20100211005 | Edwards et al. | Aug 2010 | A1 |
20120008811 | Edwards et al. | Jan 2012 | A1 |
20120226226 | Edwards et al. | Sep 2012 | A1 |
20130023822 | Edwards et al. | Jan 2013 | A1 |
20130023825 | Edwards et al. | Jan 2013 | A1 |
Number | Date | Country |
---|---|---|
1043037 | Oct 2000 | EP |
1287840 | Mar 2003 | EP |
1462134 | Sep 2004 | EP |
1712178 | Oct 2006 | EP |
55-75335 | Jun 1980 | JP |
2003-310758 | Nov 2003 | JP |
2006-034845 | Feb 2006 | JP |
WO 9104760 | Apr 1991 | WO |
WO9302720 | Feb 1993 | WO |
WO 9526009 | Sep 1995 | WO |
WO 9730742 | Aug 1997 | WO |
WO 9907425 | Feb 1999 | WO |
WO 9943283 | Sep 1999 | WO |
WO 0124690 | Apr 2001 | WO |
WO 0126020 | Apr 2001 | WO |
WO 0141849 | Jun 2001 | WO |
WO 0188828 | Nov 2001 | WO |
WO 0193926 | Dec 2001 | WO |
WO 0224257 | Mar 2002 | WO |
WO 02051471 | Jul 2002 | WO |
WO 03057283 | Jul 2003 | WO |
WO 03095001 | Nov 2003 | WO |
WO 03097133 | Nov 2003 | WO |
WO 2004041330 | May 2004 | WO |
WO 2005050526 | Jun 2005 | WO |
WO 2006045525 | May 2006 | WO |
WO 2006109778 | Oct 2006 | WO |
WO2006125692 | Nov 2006 | WO |
Entry |
---|
“Solutions for Medical Devices,” © 3M Brochure, © 3M 2006 80-6201-3490-0. |
Merle Tingelstad, “Revolutionary Medical Technology Increases Demand for Flexible Interconnects,” [online] May 15, 2006 [retrieved on Nov. 15, 2006] Retrieved from the Internet <URL: http://www.ecnmag.com/index.asp?layout=articlePrint&ArticleID=CA6332947 >. |
“Flexible circuits / Flex circuits / Flexible Technology Ltd.,” Flexible Technology Limited [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://www.flexibletechnology.com/ >. |
“Flexible circuits capabilities of Flexible Technology Limited,” Our Flexible Circuits Capabilities [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://www.flexibletechnology.com/Flexible circuits Capability.htm >. |
“Flex Circuits/flexible circuits design guide,” [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://flexiblecircuit.co.uk/Flex Circuits Design Guide.htm >. |
“Insect Stings Auto-injector Pouches and Carry Cases,” The Insect Stings On-Line Shop, [online] [retrieved on Jan. 24, 2007] Retrieved from the Internet <URL: http://www.insectstings.co.uk/acatalog/Auto Injector Pouches.html >. |
“Anaphylaxis Canada Product Catalogue,” Anaphylaxis Canada > Living with Anaphylaxis > Tools and Resources [online] [retrieved on Jan. 24, 2007] Retrieved from the Internet <URL: http://anaphylaxis.org/content/livingwith/productcatalogue.asp >. |
“Microfluidics Device Provides Programmed, Long-Term Drug Dosing,” nano techwire.com [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://nanotechwire.com/news.asp?nid=3141&ntid=124&pg=1 >. |
Roger Allan, “Medical Electronics: Technology Advances Will Revolutionize Healthcare,” Sep. 30, 2002 [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://www.elecdesign.com/Articles/Index.cfm?AD=1&ArticleID=2041>. |
RFID Gazette, “Smart Labels in Healthcare,” Sep. 29, 2005 [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://www.rfidagazeete.org/2005/09/smart labels in.html >. |
“Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device,” Jan. 30, 2007 [online] [retrieved on Feb. 5, 2007] Retrieved from the Internet <URL: http://www.biz.yahoo.com/prnews/070130/ukm028.html?.v=8. |
Dr. Oliver Scholz, “Drug depot in a tooth,” [online] [retrieved on Feb. 6, 2007] Retrieved from the Internet <URL: http://www.fraunhofer.de/fhg/EN/press/pi/2007/02Mediendienst22007Thema2.jsp?print=true. |
Heartsine Technology, samaritan™ Pad Accessories [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.heartsine.com/aboutsam-accessories.htm>. |
CliniSense Corporation, “Drug delivery devices a potentially harsh environment for drugs,” Stability [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.clinisense.com/devices.htm>. |
CliniSense Corporation, “LifeTrack Technology a new method to detect improper storage.” Stability [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.clinisense.com/tech.htm>. |
AED Professionals™ Brochure [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.aedprofessionals.com/>. |
Daniel Ruppar, “Implant Technologies Expected to Remain a Niche but Effective Method of Drug Delivery,” Drug Delivery Technology, Feb. 2007, vol. 7, No. 2 [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.drugdeliverytech-online.com/drugdelivery/200702/templates/pageviewer—print?pg=44&pm=8 >. |
Search Report and Written Opinion for International Patent Application No. PCT/US06/03415 mailed Jul. 13, 2006, 10 pages. |
Search Report and Written Opinion for International Patent Application No. PCT/US07/007626 mailed Sep. 29, 2008. |
Combined Search and Examination Report for GB 0818178.6, mailed Dec. 1, 2008. |
Office Action for U.S. Appl. No. 11/621,236, mailed Feb. 3, 2009. |
Examination Report for British Patent Application No. GB 0818178.6, mailed Mar. 23, 2009. |
Examination Report for British Patent Application No. GB 0905194.7, mailed May 8, 2009. |
Final Office Action for U.S. Appl. No. 11/621,236, mailed Jul. 1, 2009. |
Examination Report for British Patent Application No. GB 0818178.6, mailed Jul. 9, 2009. |
Search Report and Written Opinion for International Patent Application No. PCT/US09/63983, mailed Feb. 25, 2010. |
Search Report for European Patent Application No. 09150135.3, mailed Mar. 15, 2010. |
Final Office Action for U.S. Appl. No. 11/679,331, mailed Feb. 15, 2011. |
Office Action for Japanese Patent Application No. JP2009-502964, mailed May 23, 2011. |
Final Office Action for U.S. Appl. No. 11/671,025, mailed Sep. 8, 2011. |
English Translation of Office Action for Japanese Patent Application No. 2011-509613, mailed May 15, 2013. |
Non-Final Office Action for U.S. Appl. No. 13/036,720, mailed May 17, 2013. |
Non-Final Office Action for U.S. Appl. No. 13/234,649, mailed May 28, 2013. |
English Translation of Office Action for Indian Patent Application No. 5414/DELNP/2007, mailed May 21, 2013. |
Number | Date | Country | |
---|---|---|---|
20120280815 A1 | Nov 2012 | US |
Number | Date | Country | |
---|---|---|---|
60648822 | Feb 2005 | US | |
60731886 | Oct 2005 | US | |
60787046 | Mar 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11671025 | Feb 2007 | US |
Child | 13464234 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11621236 | Jan 2007 | US |
Child | 11671025 | US | |
Parent | 10572148 | US | |
Child | 11621236 | US |